NCT03566524View on ClinicalTrials.gov

Study of Arginine and Nitric Oxide in Patients With Diabetes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Ketosis Prone Diabetes
Interventions
DIETARY_SUPPLEMENT

Citrulline

Ketosis prone diabetes patients (n=10) will be randomly assigned to receive either dietary supplement of citrulline or alanine as placebo. They will then cross over to the other supplement.

DIETARY_SUPPLEMENT

Alanine

Ketosis prone diabetes patients (n=10) will be randomly assigned to receive either dietary supplement of citrulline or alanine as placebo. They will then cross over to the other supplement.

Trial Locations (1)

77030

Baylor St Lukes Medical Center, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT03566524 - Study of Arginine and Nitric Oxide in Patients With Diabetes | Biotech Hunter | Biotech Hunter